Capital Corp Essex serves as Executive at Neos Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Capital Corp Essex has executed 12 insider transactions totaling $450.0K, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 28, 2015 involved exercising options for 386,415 shares valued at $0.
Capital Corp Essex currently holds 393,704 shares of Neos Therapeutics, Inc. (NEOS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Capital Corp Essex has been a net buyer of NEOS stock. They have purchased $450.0K and sold $0 worth of shares.
Capital Corp Essex's most recent insider trade was on Jul 28, 2015, when they sold 386,415 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 83,333 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 237,500 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 20,833 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 8,333 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 56,874 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 81,249 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 18,332 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 2,958 | $N/A | Discretionary |
| Jul 28, 2015 | NEOS | $450.0K | Purchase | 30,000 | $15.00 | Discretionary |
| Jul 28, 2015 | NEOS | $0 | Conversion | 1,666 | $N/A | Discretionary |